Loading clinical trials...

Compensatory Cognitive Training For Schizophrenia | Clinical Trials | Clareo Health

COMPLETEDNA

Compensatory Cognitive Training For Schizophrenia

Compensatory Cognitive Training for Psychosocial Correlates and Self-stigma in Persons With Schizophrenia

NCT04040998•Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan

Summary

This study aimed to investigate the effects of compensatory cognitive training plus treatment as usual (CCT+TAU) versus treatment as usual (TAU) on on self-esteem, self-efficacy, quality of life, and self-stigma for schizophrenia.

Eligibility

Age

20 - 65 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•diagnosis of schizophrenia, based on the ICD-10 diagnostic criteria for research (World Health Organization, 1992)
•age from 20 to 65
•attending day care center regularly for at least 3 months
•taking stable dose of medication for at least 3 months

Exclusion Criteria

•comorbid autism spectrum disorder
•comorbid mental retardation
•lacking the reading and writing skills

Locations (1)

Taoyuan Psychiatric Center Ministry of Health and Welfare

Taoyuan District, Taiwan

Key Dates

Start Date

January 5, 2018

Primary Completion Date

May 31, 2018

Completion Date

May 31, 2018

Last Updated

August 1, 2019

Enrollment

ACTUAL participants

Conditions

Schizophrenia

Interventions

Compensatory Cognitive Training

BEHAVIORAL

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

NCT07455929

Psychotic DisordersSchizophrenia Spectrum Disorders

View study

RECRUITING

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT06740383

Schizophrenia Spectrum and Other Psychotic DisordersSchizophrenia+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 1, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Compensatory Cognitive Training For Schizophrenia

Inclusion Criteria

Exclusion Criteria

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Brain Stimulation to the Hippocampus in Schizophrenia

Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques